Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Hub Group declares quarterly dividend of $0.125 per share payable June 17, 2026

Company Fundamentals
21 May 2026
Not Specified
View Source
Neutral
pluang ai news

Hub Group, Inc. announced a quarterly cash dividend of $0.125 per share for its Class A and Class B common stock. The dividend will be paid on June 17, 2026, to shareholders recorded as of June 5, 2026. This dividend is part of Hub Group's annual dividend program totaling $0.50 per share, aligned with its growth-focused capital allocation strategy. The announcement reflects the company's ongoing commitment to returning value to shareholders while supporting its business growth.

More News

General Fusion achieves 8.4 million °C plasma heating, nearing key 1 keV milestone with LM26 fusion machine

General Fusion achieves 8.4 million °C plasma heating, nearing key 1 keV milestone with LM26 fusion machine

General Fusion has made significant progress with its LM26 Magnetized Target Fusion machine, achieving plasma electron temperatures of about 8.4 million degrees Celsius (0.72 keV), nearing its 1 keV target. This milestone demonstrates effective plasm...

Others
Bullish
37 minutes ago
AI/R advances AI integration in business with Databricks, achieving Gold partner status and boosting client results.

AI/R advances AI integration in business with Databricks, achieving Gold partner status and boosting client results.

AI/R, a technology company specializing in Agentic AI, has deepened its partnership with Databricks, achieving Gold partner status and expanding its certifications from 11 to over 100. This growth enables AI/R to deliver advanced AI and data solution...

Market News
Bullish
1 hour ago
Lebrikizumab sustains atopic dermatitis clearance up to 2 years with less frequent dosing, per new long-term data.

Lebrikizumab sustains atopic dermatitis clearance up to 2 years with less frequent dosing, per new long-term data.

New long-term data from the ADjoin trial shows that lebrikizumab, an injectable treatment for moderate to severe atopic dermatitis, maintains skin clearance and reduces itching for up to 2 years even with monthly dosing instead of biweekly. About 76%...

Market News
Bullish
2 hours ago
Greystone hires Joshua Rosen to lead seniors housing and healthcare loan origination.

Greystone hires Joshua Rosen to lead seniors housing and healthcare loan origination.

Greystone, a national commercial real estate finance company, has appointed Joshua Rosen as Senior Managing Director to focus on originating loans for seniors housing and healthcare sectors. Based in Chicago, Rosen brings extensive experience from Wa...

Market News
Bullish
2 hours ago
Investigations launched into merger deals of Apogee, Roku, TruBridge, and Organon over shareholder value concerns.

Investigations launched into merger deals of Apogee, Roku, TruBridge, and Organon over shareholder value concerns.

Brodsky & Smith LLC announced investigations into the merger agreements of Apogee Therapeutics, Roku, TruBridge, and Organon. Each investigation questions whether the respective company boards fulfilled their fiduciary duties by ensuring a fair proce...

Market News
Bearish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App